Calpain 10 and development of diabetes mellitus in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 5, Issue 1, 2006, Pages 47-51

  Derbel, Salma ^a   Doumaguet, Celine ^b   Hubert, Dominique ^b   Mosnier Pudar, Helene ^b   Grabar, Sophie ^b   Chelly, Jamel ^a   Bienvenu, Thierry ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Assistance Publique des Hôpitaux de Paris ^*  (France)

Author keywords

Calpain 10; Cystic fibrosis; dHPLC; Diabetes mellitus

Indexed keywords

CALPAIN 10;

ADULT; ARTICLE; COMORBIDITY; CYSTIC FIBROSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE ASSOCIATION; DNA SCREENING; FEMALE; FRANCE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; BLOOD GLUCOSE; CALPAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTIC FIBROSIS; DIABETES MELLITUS; DNA; FEMALE; GENOTYPE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 31344444667     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2005.09.011     Document Type: Article

References (32)

1. A.D. Mackie S.J. Thornton F.P. Edenborough Cystic fibrosis-related diabetes Diabet Med 20 2003 425-436
2. M. Lohr P. Goertchen H. Nizze et. al. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study Virchows Arch A Pathol Anat Histopathol 414 1989 179-185
3. T. Arrigo D. Cucinotta S. Conti Nibali et. al. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: Results of a two-year follow-up Acta Paediatr 82 1993 249-253
4. L.E. Kopito H. Shwachman The pancreas in cystic fibrosis: Chemical composition and comparative morphology Pediatr Res 10 1976 742-749
5. K. Soejima B.H. Landing Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: Morphometric and immunocytologic studies Pediatr Pathol 6 1986 25-46
6. A. Austin S.C. Kalhan D. Orenstein P. Nixon S. Arslanian Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis J Clin Endocrinol Metab 79 1994 80-85
7. D.S. Hardin A. LeBlanc L. Para D.K. Seilheimer Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis Diabetes 48 1999 1082-1087
8. A. Moran K.L. Pyzdrowski J. Weinreb et. al. Insulin sensitivity in cystic fibrosis Diabetes 43 1994 1020-1026
9. T. Ahmad R. Nelson R. Taylor Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis Metabolism 43 1994 163-167
10. D. Cucinotta S. Conti Nibali T. Arrigo et. al. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance Horm Res 34 1990 33-38
11. M.I. McCarthy Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification Hum Mol Genet 13 2004 R33-R41
12. S. Suter U.B. Schaad P. Roux-Lombard E. Girardin G. Grau J.M. Dayer Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis Am Rev Respir Dis 140 1989 1640-1644
13. E. Levy C. Gurbindo F. Lacaille K. Paradis L. Thibault E. Seidman Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis Pediatr Res 34 1993 162-166
14. Y. Horikawa N. Oda N.J. Cox et. al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus Nat Genet 26 2000 163-175
15. M.J. Riedel P. Boora D. Steckley G. de Vries P.E. Light Kir6.2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: A possible cellular mechanism for increased susceptibility to type 2 diabetes? Diabetes 52 2003 2630-2635
16. M. Mohlig H. Boeing J. Spranger Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes J Clin Endocrinol Metab 89 2004 1885-1890
17. J.A. McKenzie E.P. Weiss I.A. Ghiu et. al. Influence of the interleukin-6 -174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indices J Appl Physiol 4 2004 4-14
18. L.J. Baier P.A. Permana X. Yang et. al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance J Clin Invest 106 2000 R69-R73
19. J.W. Stephens S.J. Hurel J.A. Cooper J. Acharya G.J. Miller S.E. Humphries A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus Mol Genet Metab 82 2004 180-186
20. M. Stumvoll A. Fritsche A. Madaus et. al. Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans Diabetes 50 2001 2161-2163
21. A. Kretowski K. Mironczuk A. Karpinska et. al. Interleukin-18 promoter polymorphisms in type 1 diabetes Diabetes 51 2002 3347-3349
22. C. Schwanstecher B. Neugebauer M. Schulz M. Schwanstecher The common single nucleotide polymorphism E23K in K(IR)6.2 sensitizes pancreatic beta-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphates Diabetes 51 2002 S363-S367
23. M. Orho-Melander M. Klannemark M.K. Svensson M. Ridderstrale C.M. Lindgren L. Groop Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels Diabetes 51 2002 2658-2664
24. A. Kubaszek J. Pihlajamaki K. Punnonen P. Karhapaa I. Vauhkonen M. Laakso The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity Diabetes 52 2003 558-561
25. E.M. Nielsen L. Hansen B. Carstensen et. al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes Diabetes 52 2003 573-577
26. M. Stephens N.J. Smith P. Donnelly A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 2001 978-989
27. C.E. Milla W.J. Warwick A. Moran Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline Am J Respir Crit Care Med 162 2000 891-895
28. C. Marshall G.A. Hitman C.J. Partridge A. Clark H. Ma T.R. Shearer et. al. Evidence that an isoform in calpain-10 is a regulator of exocytosis in pancreatic β-cells Mol Endocrinol 19 2005 213-224
29. K. Suzuki S. Hata Y. Kawabata H. Sorimachi Structure, activation, and biology of calpain Diabetes 53 2004 S12-S18
30. M. Marre P. Bernadet Y. Gallois et. al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications Diabetes 43 1994 384-388
31. S.C. Elbein W. Chu Q. Ren et. al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians J Clin Endocrinol Metab 87 2002 650-654
32. Y. Shima K. Nakanishi M. Odawara T. Kobayashi H. Ohta Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese Clin Chim Acta 336 2003 89-96